Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cytosorbents (CTSO) Asset Utilization Ratio (2016 - 2026)

Cytosorbents filings provide 13 years of Asset Utilization Ratio readings, the most recent being 0.82 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 10.19% to 0.82 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.82, a 10.19% increase, with the full-year FY2025 number at 0.81, up 14.1% from a year prior.
  • Asset Utilization Ratio hit 0.82 in Q4 2025 for Cytosorbents, up from 0.79 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.82 in Q4 2025 to a low of 0.46 in Q3 2021.
  • Median Asset Utilization Ratio over the past 5 years was 0.68 (2023), compared with a mean of 0.63.
  • Biggest five-year swings in Asset Utilization Ratio: tumbled 39.18% in 2021 and later surged 37.11% in 2023.
  • Cytosorbents' Asset Utilization Ratio stood at 0.47 in 2021, then increased by 18.2% to 0.55 in 2022, then soared by 30.81% to 0.72 in 2023, then grew by 3.44% to 0.75 in 2024, then increased by 10.19% to 0.82 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.82 (Q4 2025), 0.79 (Q3 2025), and 0.73 (Q2 2025) per Business Quant data.